Memory Lift Reviews & Complaints 2025: Is This Brain Supplement Worth Trying? (BUYER WARNING)
TALLMADGE, OH / ACCESS Newswire / September 13, 2025 / Memory Lift is a brain health supplement that is said...
Brain
Interim results for the six months ended June 30, 2025
September 12, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2025 Biodexa...
Sophont, Founded by 22-Year-Old Innovator, Raises $9.22M Seed Round to Transform Healthcare with Multimodal AI
SACRAMENTO, Calif., Sept. 11, 2025 /PRNewswire/ -- Sophont, a medical AI startup, announced the closing of its $9.22M pre-seed and...
Amplifire’s adaptive learning platform drives transformational EHR training success at Ochsner Health
BOULDER, Colo., Sept. 11, 2025 /PRNewswire/ -- Amplifire, a leader in adaptive learning and workforce development, is sharing best practices...
MIXT IV Spa: Bringing Modern IV Therapy to Los Alamitos & Surrounding Cities
MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving...
MIXT IV Spa: Bringing Modern IV Therapy to Los Alamitos & Surrounding Cities
MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving...
Prof. Ahmad AbuSalah: KFSHRC’s Sustainable Digital Innovation Ecosystem Features 30+ AI Solutions and 5 New Agents in 2025
Prof. Ahmad AbuSalah: KFSHRC’s Sustainable Digital Innovation Ecosystem Features 30+ AI Solutions and 5 New Agents in 2025 Prof. Ahmad...
RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma
Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to advance innovative Theranostic radiopharmaceuticals to address unmet needs...
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer
Scientific Advisory Board member, Dr. Noriyuki Kasahara, appointed Chief Scientific Officer of GenVivo, to accelerate the achievement of major clinical...
Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
Safety endpoint met, with encouraging signs of efficacy in trial with 23 patients suffering from intracerebral hemorrhage (ICH)Findings suggest BIOX-101...
US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker
September 11, 2025News Release US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker COPENHAGEN, DENMARK...
Scancell reports Business Update and Financial Results for the Year Ended 30 April 2025
NOTTINGHAM, United Kingdom, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope®...
Keystone Place at Newbury Brook Senior Living Community Expands with 39 New Apartments, Launches Innovative Transitional Memory Care.
TORRINGTON, CT , Sept. 10, 2025 (GLOBE NEWSWIRE) -- In response to the growing demands for senior living apartments, Keystone...
Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share
Calgary, Alberta--(Newsfile Corp. - September 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Company"), the leading autologous...
Luminopia Partners with Pokémon to Expand Its Curated Content Library for Pediatric Amblyopia Patients
Children using Luminopia now have access to hundreds of episodes from the original Pokémon animated series, making amblyopia treatment even...
Longevity Takes the Spotlight: Global Wellness Summit Announces First Wave of Trailblazing Speakers for 19th Annual Gathering
From gene editing breakthroughs to AI-driven drug discovery to epigenetic interventions, this year's Summit explores the radical advances reshaping how...
The Brain Aneurysm Foundation Announces its 2025 Research Grant Recipients
Close to $600,000 in Funding Provided to 14 Academic Researchers from Across the US to Advance New Innovations to Predict,...
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
Cumulus Neuroscience Appoints Robert Ballantine to Board of Directors
BELFAST, Northern Ireland, Sept. 10, 2025 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing...
NeuroKaire launches first-of-its-kind clinical test in the US, expected to dramatically reduce the ‘trial and error’ approach to finding the right antidepressant
NeuroKaire's blood-based screening tool, BrightKaire,™ is also expected to save more than $16 billion annually in avoidable treatment costs. KEARNY,...